Feds Seek Prison For Exec's FDA Fraud After 1st Circ. Flip
Federal prosecutors want an executive at a defunct lab tied to a deadly meningitis outbreak to spend 18 months in prison after the First Circuit reinstated his conviction for concealing pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article